Etcembly are thrilled to be partnering with Zelluna once again as we push the boundaries of AI‑enabled TCR engineering.

Building on the success of our previous work together on the MAGE‑A4 TCR — which now underpins ZI‑MA4‑1 and has recently received MHRA approval to enter the clinic — this new partnering between Etcembly and Zelluna focuses on engineering next‑generation KKLC1‑targeting TCRs using our AI‑driven EMLy™ platform. Find out more here >